Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
Diabetic Kidney Disease (DKD) is the leading cause of chronic kidney disease in developed countries and its prevalence has increased dramatically in the past few decades. These patients are at an increased risk for premature death, cardiovascular disease, and other severe illnesses that result in fr...
Main Authors: | Luz Lozano-Maneiro, Adriana Puente-García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/4/11/1908 |
Similar Items
-
Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study
by: Sehoon Park, et al.
Published: (2019-09-01) -
Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01) -
Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease
by: Mona A. Abdelrahman, et al.
Published: (2016-09-01) -
Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
by: Yan-Huan Feng, et al.
Published: (2016-01-01) -
Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
by: Anastasia V. Poznyak, et al.
Published: (2021-06-01)